GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
“I would also like to take this opportunity to thank Heinz Jacqui for his valuable contribution and dedicated work during his time with the Group.”
Getinge Group (STO:GETIB) has appointed Jens Viebke as the new President of the Acute Care Therapies Business Category Unit. Jens will be a member of the Getinge Group Executive Team and succeeds Heinz Jacqui who will step down from his current position after four years with the Group. Acute Care Therapies is one of Getinge’s three Business Category Units and is responsible for developing technologies and solutions for cardiac, pulmonary and vascular therapies and products and therapies for intensive care.
The Group has made significant investments in quality management systems in recent years, particularly in areas related to the Acute Care Therapies Business Category Unit. Intense focus continues to be directed to completing the necessary improvement measures for building up a global quality management system with the desired standard.
The product segments in Acute Care Therapies, where Getinge has a strong pipeline of new products, have significant growth potential and investments continue to be made in developing pioneering technologies and solutions.
“I am very pleased to present Jens Viebke as the new President of our Acute Care Therapies Business Category Unit. We have faced a number of challenges related to this product area in recent years and I have every confidence in Jens using his extensive experience and expertise to lead the operations in the right direction. With his comprehensive knowledge in the field of research and development, coupled with his commercial experience, Jens will be a major asset for the Group in his new role,” says Alex Myers, CEO and President of Getinge, who concludes: “I would also like to take this opportunity to thank Heinz Jacqui for his valuable contribution and dedicated work during his time with the Group.”
Jens Viebke most recently served as Chief Technology Officer at Acute Care Therapies and was previously the President of the Critical Care division in the Group’s former Medical Systems business area. Jens has long and broad experience from the healthcare industry and has previously held positions in research and development, as well as strategy and marketing, at other large companies in the industry, including GE Healthcare and Pharmacia & Upjohn. Jens has a PhD in Polymer Technology from the Royal Institute of Technology of Stockholm and holds an Executive MBA from the Stockholm School of Economics.
Jens Viebke will take up his new position as of June 6, 2016, and will report to Alex Myers, President & CEO Getinge Group.
Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge’s unique customer offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Based on first-hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow.
This information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
This information was brought to you by Cision http://news.cision.com
Contacts
Getinge Group
Alex Myers
CEO and President
Tel: +46 10 335 00 00
E-mail: alex.myers@getinge.com
or
Kornelia Rasmussen
Executive Vice President, Corporate Communications & Brand Management
Tel: +46 10 335 5810
E-mail: kornelia.rasmussen@getinge.com
